Cancer drug shows promise in reducing toxic genetic material in myotonic dystrophy
Thursday, December 10, 2015 - 14:10
in Health & Medicine
A drug used to treat cancer can neutralize the toxic RNA that causes the prolonged muscle contractions and other symptoms of myotonic dystrophy type 1, the most common form of adult-onset muscular dystrophy, a group of researchers has shown for the first time in cells and in a mouse model.